Surgynal

What Surgynal does

Surgynal is a French medical device company founded in 2010 and headquartered in Dardilly, in the Lyon metropolitan area. The company specializes in the distribution and commercialization of surgical solutions for uro-gynecological pathologies, with a particular focus on pelvic floor disorders affecting women and men. Its core product portfolio includes textile-based surgical implants for prolapse correction (HALBA MESH, PROCUR PET, PROCUR PP H), sub-urethral slings for stress urinary incontinence (TOT and TVT bands), submucosal injection kits for incontinence treatment, surgical instrumentation for pelvic surgery (CLEARPETRA, UTEROCLIP, GALAXY, LUX), and uroflowmetry diagnostic platforms (HOMEFLOW, HOSPIFLOW). Surgynal both develops proprietary products and serves as the exclusive French distributor of the COMBAT BRS thermochemotherapy system from Combat Medical for bladder cancer treatment.

In August 2024, the company expanded into male urology with the launch of a Benign Prostatic Hyperplasia (HBP) product line, comprising the Catheter de Schelin for prostatic capsule local anesthesia, the Stent CoreFlow temporary prostatic stent, and the MiLEP laser enucleation system distributed via RZ-Medizintechnik. Surgynal also offers Surgy'POP, an animated anatomical illustration tool designed to support surgeons in patient education on prolapse pathologies and treatment options.

The business model centers on direct field sales of medical devices to French public hospitals, private clinics, and individual urology and gynecology surgeons. The company engages its clinical customer base through medical congress participation (SIFUD-PP, EAU), a quarterly newsletter (SurgyNews), surgical procedure video content, surgeon training and companionship programs, and a presence on LinkedIn, Facebook, and Twitter. Strategic distribution partnerships with Combat Medical, PROSTALUND, RZ-Medizintechnik, Aqlane Medical, and IntAir Medical underpin the product range. Surgynal employs 1-10 people, operates exclusively in France, and is privately held with no disclosed funding rounds or investor composition.

Name

Surgynal

Legal name

SURGYNAL

Website

https://surgynal.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

1–10 employees

Short description

Surgynal is a French medical device company founded in 2010 that distributes and develops proprietary uro-gynecological surgical solutions — including prolapse implants, incontinence slings, BPH devices, and the exclusive COMBAT BRS bladder cancer system — selling directly to French hospitals, clinics, and specialist surgeons.

Ownership category

akta.pro rank

Product category

Uro-Gynecological Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Female Pelvic Medicine & Reconstructive Surgery (Urogynecology) (HLAKAOAC)

akta.pro secondary industries

Urogynecology & Pelvic Reconstructive Surgery (Female Pelvic Medicine) (HLAKAJAE), General Urology (HLAKAOAA), Urologic Oncology (HLAKAOAB), Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

Keywords

• Uro-gynecological medical devices
• Pelvic floor surgical implants
• Urinary incontinence slings
• Benign prostatic hyperplasia devices
• Urological surgical instruments

Headquarters

HQ city

Lyon

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Surgical Medical Devices Distribution: Surgynal commercializes a range of innovative surgical solutions for uro-gynecological pathologies. The company develops its own proprietary products (implants, instruments) and distributes exclusive products from international partners in France. Revenue is generated through the sale of medical devices and implants to hospital and clinic buyers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Surgynal develops, manufactures, and distributes implantable medical devices and surgical instruments for uro-gynecology and pelvic floor pathologies. Its portfolio includes textile-based surgical meshes and slings (TOT, TVT) for prolapse correction and stress urinary incontinence, thermochemotherapy systems for bladder cancer, uroflowmetry diagnostic platforms, surgical instrumentation, and minimally invasive devices for benign prostatic hyperplasia (BPH). The company combines proprietary product development with exclusive French distribution of partner products.

Product overview

Surgynal is a French medical device company specializing in uro-gynecological surgical solutions, operating since 2010 as a unique actor in innovative surgical treatments for pelvic floor pathologies in women and men. The company offers a comprehensive portfolio centered on implants for prolapse correction (Prolapsus), incontinence treatment bands (TOT, TVT), and submucosal injection kits. The product range extends to cancerology with the COMBAT BRS thermochemotherapy system for bladder cancer, diagnostic equipment including HOMEFLOW/HOSPIFLOW uroflowmetry platforms, and a full instrumentation line (CLEARPETRA, UTEROCLIP, GALAXY, LUX). Recently expanded in 2024 to include Benign Prostatic Hyperplasia (HBP) treatments with the Catheter de Schelin for local anesthesia, Stent CoreFlow temporary prostatic stents, and MiLEP laser enucleation products. The company also provides Surgy'POP, an animated anatomical illustration tool for patient education on prolapse pathologies and treatments.

Differentiator

Problem solved

Functional benefit

Brands

• Surgy'POP: Animated anatomical illustration tool for presenting prolapse pathologies and treatment options to patients

Products and services

• Prolapse Implants (Implants pour Prolapsus)

Quantifiable outcome

• It is estimated that 11% of women will suffer from pelvic organ prolapse during their lifetime

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Four partnerships are on record, tiered minor and core.

• IntAir MedicalminorChannel Partner/ Reseller/ DistributorIntAir Medical is shown as a partner. The partnership likely involves distribution or complementary product offerings in the urology/gynecology space.
• Combat MedicalcoreChannel Partner/ Reseller/ DistributorSurgynal is the exclusive distributor in France of the COMBAT BRS device from Combat Medical for the treatment of bladder cancer via thermochemotherapy. This is a core exclusive distribution partnership for Surgynal's cancérologie (cancerology) product line.
• PromedonminorChannel Partner/ Reseller/ DistributorSurgynal participated in the European Association of Urology 2017 congress in London in partnership with Promedon, suggesting a co-marketing or joint presence relationship at industry events.
• SIFUD-PPminorOthersSurgynal follows and participates in SIFUD-PP (Société Interdisciplinaire Francophone d'Urodynamique et de Pelvi-Périnéologie), a professional society. Surgynal was present at the 40th SIFUD-PP congress.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Caldera Medical: Caldera Medical is a US-based medical device company exclusively focused on women's pelvic health, developing surgical solutions for stress urinary incontinence and pelvic organ prolapse. Caldera directly competes with Surgynal's mesh implant and sling product lines in the same clinical use cases.
• Coloplast: Coloplast is a global leader in ostomy, continence, wound, and skin care, with a significant urogynecology and pelvic floor franchise including slings and mesh implants for incontinence treatment. Coloplast directly competes with Surgynal's TOT/TVT sling and prolapse implant categories across European markets.
• Promedon: Promedon is an Argentina-based medical device company specializing in urogynecology, pelvic floor reconstruction, and sling implants. Promedon is both a competitor in the prolapse and incontinence implant category and is also a documented partner of Surgynal for co-marketing at industry events such as EAU 2017.
• Laborie Medical Technologies: Laborie is a global medical device company specializing in urology and urogynecology diagnostics and therapeutics, including uroflowmetry devices and incontinence treatment products. Laborie directly competes with Surgynal's HOMEFLOW/HOSPIFLOW diagnostic platform and broader urogynecology portfolio.

Emerging players

• Neomedic International: Neomedic International is a medical device company focused on pelvic floor reconstruction, sling implants for incontinence, and urogynecological surgical solutions. Neomedic competes with Surgynal in mesh implant and sling categories with focused specialty positioning.
• AMI (Agency for Medical Innovations): AMI is an Austrian medical device company specializing in surgical implants for urogynecology, hernia repair, and pelvic floor reconstruction. AMI directly competes with Surgynal in the European pelvic floor implant market with comparable niche specialization.

Broad incumbents

• Ethicon (Johnson & Johnson): Ethicon, a J&J MedTech company, has historically been a major player in urogynecology with TVT sling systems and other women's health surgical products. Ethicon competes with Surgynal in incontinence and prolapse markets as part of its broad surgical portfolio.
• Cook Medical: Cook Medical is a privately-held multinational medical device company with urology and women's health product lines including pelvic floor implants and surgical instruments. Cook overlaps with Surgynal in pelvic surgery instrumentation and implant categories across global markets.
• Medtronic: Medtronic is a global medical device leader with a significant urology franchise including BPH treatment devices and incontinence therapies. Medtronic competes with Surgynal's recently-launched BPH product line and overlaps in broader pelvic surgery categories.
• Boston Scientific: Boston Scientific is a major multinational medical device company with established urogynecology and pelvic floor product lines including sling systems. Boston Scientific overlaps with Surgynal across incontinence and pelvic floor treatment categories but operates at vastly larger scale with broader portfolio coverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/surgynal
• Facebookfacebook.com/Surgynal
• LinkedInlinkedin.com/company/surgynal

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgynal